Collateral flow channel sealant delivery methods and systems

Inventors

Radhakrishnan, Sri • Olivera, Ryan

Assignees

Pulmonx Corp

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11696763-B2

Patent

Publication Date

2023-07-11

Expiration Date


Abstract

Devices, methods, and systems are provided for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. A video-assisted thoracoscopic device is inserted into a thoracic cavity of a patient and positioned at a fissure between a target lung compartment and an adjacent lung compartment. A collateral flow channel between the target lung compartment and the adjacent lung compartment is then identified using the video-assisted thoracoscopic device and an agent is injected into the collateral flow channel, thereby reducing the collateral flow channel.

Core Innovation

The disclosed subject matter relates to methods for occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment. The disclosed approaches center on disrupting or reducing the channel, or closing tissue at the channel; [procedural detail omitted for safety]. The methods also encompass identifying the channel and assessing closure through pressure or flow measurements.

The provided disclosure further details deploying an endobronchial one-way valve associated with the target lung compartment, which allows exhalation while preventing inhalation to support target-region volume reduction. The subject matter therefore encompasses collateral flow channel occlusion and, in certain embodiments, cooperative endobronchial one-way airflow control; [procedural detail omitted for safety].

Claims Coverage

The claims identify three inventive features across three independent claims directed to occluding a collateral flow channel between a target lung compartment and an adjacent lung compartment.

Disruption of the collateral flow channel

Independent claim 1 covers disrupting tissue at the collateral flow channel using a cutting device; [procedural detail omitted for safety].

Reduction of the collateral flow channel using an agent

Independent claim 6 covers reducing the collateral flow channel through use of an agent; [procedural detail omitted for safety].

Closure of tissue at the collateral flow channel

Independent claim 15 covers disrupting the collateral flow channel by closing tissue with a closing device; [procedural detail omitted for safety].

The three independent claims address channel occlusion through tissue disruption, agent-based reduction, or mechanical tissue closure, with dependent claims addressing channel identification, closure or agent options, and endobronchial one-way airflow control.

Stated Advantages

The endobronchial one-way valve allows exhalation while preventing inhalation to support target-region volume reduction.

Documented Applications

Occlusion of a collateral flow channel between a target lung compartment and an adjacent lung compartment.

Use of an endobronchial one-way valve to support target-region volume reduction.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.